Comment from Viteyes' UK distributor

Viteyes' UK distributor Butterflies Healthcare comments on the Drugs and Therapeutics Bulletin report:

'We are pleased that the Drugs and Therapeutics Bulletin (DTB) has recognised the Viteyes range of supplements as being one which contains an appropriate combination of vitamins and minerals which may be of help to some sufferers of macular degeneration.

'We also agree that their use has only been shown to be of benefit for certain groups of people.

'The MHRA has indeed contacted us and following consultation with them we are amending our marketing and product labelling to ensure that we do not make claims of a medicinal nature.

'Specifically we have to remove all reference to AREDS from our products. Although this is the formulation they contain, by referring to the specific study it is said to be a medicinal claim.